Dr. Kedar Kirtane, MD
Claim this profileMoffitt Cancer Center
Studies Squamous Cell Carcinoma
Studies Thyroid Cancer
10 reported clinical trials
21 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
PD-L1 positive
p16 positive
2Thyroid Cancer
Stage IV
p16 positive
Stage III
Affiliated Hospitals
Clinical Trials Kedar Kirtane, MD is currently running
A2B530 CAR T Therapy
for Solid Cancers
This trial tests A2B530, a treatment using modified immune cells from the patient, in adults with hard-to-treat cancers like colorectal, pancreatic, and lung cancer. The treatment aims to target and kill cancer cells while protecting healthy cells.
Recruiting1 award Phase 1 & 27 criteria
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
More about Kedar Kirtane, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Kedar Kirtane, MD has experience with
- Pembrolizumab
- Cisplatin
- Aldesleukin
- Cyclophosphamide
- Fludarabine
- Platinum Based Chemotherapy
Breakdown of trials Kedar Kirtane, MD has run
Squamous Cell Carcinoma
Thyroid Cancer
Cancer
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kedar Kirtane, MD specialize in?
Kedar Kirtane, MD focuses on Squamous Cell Carcinoma and Thyroid Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are PD-L1 positive.
Is Kedar Kirtane, MD currently recruiting for clinical trials?
Yes, Kedar Kirtane, MD is currently recruiting for 7 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Kedar Kirtane, MD has studied deeply?
Yes, Kedar Kirtane, MD has studied treatments such as Pembrolizumab, Cisplatin, Aldesleukin.
What is the best way to schedule an appointment with Kedar Kirtane, MD?
Apply for one of the trials that Kedar Kirtane, MD is conducting.
What is the office address of Kedar Kirtane, MD?
The office of Kedar Kirtane, MD is located at: Moffitt Cancer Center, Tampa, Florida 33136 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.